Ironwood Pharmaceuticals (IRWD) Non-Current Receivables (2018 - 2022)
Historic Non-Current Receivables for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Q4 2022 value amounting to $14.6 million.
- Ironwood Pharmaceuticals' Non-Current Receivables fell 3920.74% to $14.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $14.6 million, marking a year-over-year decrease of 3920.74%. This contributed to the annual value of $14.6 million for FY2022, which is 3920.74% down from last year.
- Ironwood Pharmaceuticals' Non-Current Receivables amounted to $14.6 million in Q4 2022, which was down 3920.74% from $14.4 million recorded in Q3 2022.
- Over the past 5 years, Ironwood Pharmaceuticals' Non-Current Receivables peaked at $32.6 million during Q4 2019, and registered a low of $14.1 million during Q1 2022.
- In the last 5 years, Ironwood Pharmaceuticals' Non-Current Receivables had a median value of $23.2 million in 2020 and averaged $22.1 million.
- Its Non-Current Receivables has fluctuated over the past 5 years, first surged by 5522.38% in 2019, then crashed by 3997.79% in 2022.
- Ironwood Pharmaceuticals' Non-Current Receivables (Quarter) stood at $21.0 million in 2018, then soared by 55.22% to $32.6 million in 2019, then decreased by 28.21% to $23.4 million in 2020, then increased by 2.55% to $24.0 million in 2021, then plummeted by 39.21% to $14.6 million in 2022.
- Its Non-Current Receivables stands at $14.6 million for Q4 2022, versus $14.4 million for Q3 2022 and $14.3 million for Q2 2022.